MDS Posts 24 Percent Q2 Revenues Growth | GenomeWeb
NEW YORK (GenomeWeb News) – MDS today reported that its second-quarter 2008 revenues rose 24 percent, though only 5 percent excluding the impact of currency exchange and acquisitions.
 
The Toronto-based firm brought in revenues of $326 million for the three-month period ended April 30, compared to $263 million in the comparable period of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.